Back to Report Store Home

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Published: Aug-2018
  • Report Code: GBIHC044IDB
  • Report Format: pdf

Description

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 Pancreatic and Bile Duct Cancer Report Coverage

3.2 Pancreatic Cancer – Overview

3.3 Bile Duct Cancer (Cholangiocarcinoma) – Overview

3.4 GBI Research Report Guidance

4 Therapeutics Development

4.1 Pancreatic Cancer

4.2 Bile Duct Cancer (Cholangiocarcinoma)

5 Therapeutics Assessment

5.1 Pancreatic Cancer

5.2 Bile Duct Cancer (Cholangiocarcinoma)

6 Companies Involved in Therapeutics Development

6.1 Pancreatic Cancer

6.2 Bile Duct Cancer (Cholangiocarcinoma)

7 Dormant Projects

7.1 Pancreatic Cancer

7.2 Bile Duct Cancer (Cholangiocarcinoma)

8 Discontinued Products

8.1 Pancreatic Cancer

8.2 Bile Duct Cancer (Cholangiocarcinoma)

9 Product Development Milestones

9.1 Pancreatic Cancer

9.2 Bile Duct Cancer (Cholangiocarcinoma)

10 Appendix

10.1 Methodology

10.2 Coverage

10.3 Secondary Research

10.4 Primary Research

10.5 Expert Panel Validation

10.6 Contact Us

10.7 Disclaimer

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards